drugset / Trial / NCT02337062
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
RandomizedParallel-groupQuadruple-blindPrevention
Summary
A comparison of the efficacy of APD421 and placebo when combined with a standard anti-emetic in the prevention of PONV in patients at high risk of Post-operative Nausea and Vomiting (PONV).
Timeline
- Start
- 2015-02
- Primary completion
- 2015-09
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amisulpride | Small molecule | — | Intravenous |
Indications
No indication recorded.